The estimated Net Worth of Mark John Austin is at least $20.7 ezer dollars as of 8 June 2022. Mr. Austin owns over 18,800 units of Perspective Therapeutics Inc stock worth over $20,748 and over the last 7 years he sold ISR stock worth over $0. In addition, he makes $0 as Controller és Co-Principal Financial and Principal Accounting Officer at Perspective Therapeutics Inc.
Mark has made over 5 trades of the Perspective Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 18,800 units of ISR stock worth $5,452 on 8 June 2022.
The largest trade he's ever made was buying 19,230 units of Perspective Therapeutics Inc stock on 22 October 2020 worth over $10,000. On average, Mark trades about 5,403 units every 166 days since 2017. As of 8 June 2022 he still owns at least 54,030 units of Perspective Therapeutics Inc stock.
You can see the complete history of Mr. Austin stock trades at the bottom of the page.
Mark John Austin serves as Controller, Co-Principal Financial and Principal Accounting Officer of the Company. Prior to joining the Company, Mr. Austin, served as a Senior Manager (and before that, as a Manager/Senior Associate) at KPMG in Portland, Oregon, since 2009, where he served as lead for financial statement and internal control audits within the technology industry, including for software and manufacturing companies. While at KPMG, Mr. Austin served as lead manager for a global public company; reviewed complex software revenue transactions, including working with the revenue controller and accounting team; reviewed several transactions in accordance with ASC 805; supervised, coached, and lead teams and team members; and researched technical accounting issues relevant to the technology industry. Mr. Austin is a CPA and holds a Bachelor of Science in Commerce degree (major in accounting with an emphases in finance), from Santa Clara University, in Santa Clara, California.
Mark Austin is 31, he's been the Controller és Co-Principal Financial and Principal Accounting Officer of Perspective Therapeutics Inc since 2019. There are 16 older and no younger executives at Perspective Therapeutics Inc. The oldest executive at Perspective Therapeutics Inc is Philip Vitale, 73, who is the Independent Director.
Mark's mailing address filed with the SEC is 350 HILLS ST, STE 106, , RICHLAND, WA, 99354.
Over the last 18 years, insiders at Perspective Therapeutics Inc have traded over $0 worth of Perspective Therapeutics Inc stock and bought 1,651,741 units worth $855,397 . The most active insiders traders include Lori A Woods, Thomas C Lavoy és Dwight William Babcock. On average, Perspective Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $14,501. The most recent stock trade was executed by Lori A Woods on 13 April 2023, trading 187,500 units of ISR stock currently worth $114,375.
Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium Blu brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body.
Perspective Therapeutics Inc executives and other stock owners filed with the SEC include: